Wells Fargo & Company Exact Sciences Corp Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Exact Sciences Corp stock. As of the latest transaction made, Wells Fargo & Company holds 146,194 shares of EXAS stock, worth $8.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
146,194
Previous 143,582 1.82%
Holding current value
$8.5 Million
Previous $6.07 Million 64.09%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$42.43 - $70.83 $110,827 - $185,007
2,612 Added 1.82%
146,194 $9.95 Million
Q2 2024

Aug 13, 2024
SELL
$41.33 - $74.26 $6.25 Million - $11.2 Million
-151,281 Reduced 51.31%
143,582 $6.07 Million
Q1 2024

May 10, 2024
SELL
$56.27 - $73.77 $2.6 Million - $3.4 Million
-46,119 Reduced 13.53%
294,863 $20.4 Million
Q4 2023

Feb 09, 2024
SELL
$59.06 - $75.72 $5.4 Million - $6.92 Million
-91,353 Reduced 21.13%
340,982 $25.2 Million
Q3 2023

Nov 13, 2023
BUY
$65.94 - $99.04 $3.36 Million - $5.05 Million
51,030 Added 13.38%
432,335 $29.5 Million
Q2 2023

Aug 15, 2023
BUY
$62.68 - $95.05 $641,843 - $973,312
10,240 Added 2.76%
381,305 $35.8 Million
Q1 2023

May 12, 2023
BUY
$47.19 - $70.77 $4.7 Million - $7.05 Million
99,554 Added 36.67%
371,065 $25.2 Million
Q4 2022

Feb 13, 2023
SELL
$30.35 - $53.15 $151,021 - $264,474
-4,976 Reduced 1.8%
271,511 $13.4 Million
Q3 2022

Nov 14, 2022
BUY
$31.97 - $49.37 $636,330 - $982,660
19,904 Added 7.76%
276,487 $8.98 Million
Q2 2022

Aug 12, 2022
BUY
$35.61 - $76.23 $616,409 - $1.32 Million
17,310 Added 7.23%
256,583 $10.1 Million
Q1 2022

May 16, 2022
BUY
$57.56 - $82.54 $4.05 Million - $5.81 Million
70,402 Added 41.69%
239,273 $16.7 Million
Q4 2021

Feb 14, 2022
SELL
$72.5 - $100.68 $4.08 Million - $5.67 Million
-56,313 Reduced 25.01%
168,871 $13.1 Million
Q3 2021

Nov 15, 2021
SELL
$90.24 - $124.05 $2.41 Million - $3.31 Million
-26,719 Reduced 10.61%
225,184 $21.5 Million
Q2 2021

Aug 16, 2021
SELL
$93.66 - $139.27 $6.14 Million - $9.13 Million
-65,532 Reduced 20.64%
251,903 $31.3 Million
Q1 2021

May 13, 2021
SELL
$116.57 - $155.01 $194 Million - $258 Million
-1,667,154 Reduced 84.01%
317,435 $41.8 Million
Q4 2020

Feb 09, 2021
SELL
$99.61 - $142.12 $28.4 Million - $40.5 Million
-284,843 Reduced 12.55%
1,984,589 $263 Million
Q3 2020

Nov 05, 2020
SELL
$72.92 - $102.01 $71.4 Million - $99.9 Million
-979,061 Reduced 30.14%
2,269,432 $231 Million
Q2 2020

Aug 13, 2020
BUY
$55.75 - $92.75 $12.7 Million - $21.1 Million
227,010 Added 7.51%
3,248,493 $282 Million
Q1 2020

May 14, 2020
BUY
$37.9 - $104.44 $115 Million - $316 Million
3,021,483 New
3,021,483 $175 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email